As of 2026-04-08, the Relative Valuation of Beam Therapeutics Inc (BEAM) is (17.75) USD. This relative valuation is based on P/E multiples. With the latest stock price at 24.49 USD, the upside of Beam Therapeutics Inc based on Relative Valuation is -172.5%.
The range of the Relative Valuation is (16.99) - (19.35) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.6x - 26.2x | 23.8x |
| Forward P/E multiples | 21.0x - 24.6x | 21.4x |
| Fair Price | (16.99) - (19.35) | (17.75) |
| Upside | -169.4% - -179.0% | -172.5% |
| Date | P/E |
| 2026-04-06 | -30.85 |
| 2026-04-02 | -31.40 |
| 2026-04-01 | -30.84 |
| 2026-03-31 | -30.34 |
| 2026-03-30 | -27.89 |
| 2026-03-27 | -28.26 |
| 2026-03-26 | -30.08 |
| 2026-03-25 | -29.44 |
| 2026-03-24 | -30.50 |
| 2026-03-23 | -32.05 |
| 2026-03-20 | -31.36 |
| 2026-03-19 | -32.05 |
| 2026-03-18 | -32.24 |
| 2026-03-17 | -32.89 |
| 2026-03-16 | -32.46 |
| 2026-03-13 | -32.04 |
| 2026-03-12 | -32.59 |
| 2026-03-11 | -33.21 |
| 2026-03-10 | -33.21 |
| 2026-03-09 | -35.17 |
| 2026-03-06 | -33.80 |
| 2026-03-05 | -32.50 |
| 2026-03-04 | -34.94 |
| 2026-03-03 | -34.66 |
| 2026-03-02 | -36.53 |
| 2026-02-27 | -36.24 |
| 2026-02-26 | -36.83 |
| 2026-02-25 | -37.70 |
| 2026-02-24 | -41.12 |
| 2026-02-23 | -36.07 |
| 2026-02-20 | -35.13 |
| 2026-02-19 | -35.50 |
| 2026-02-18 | -35.09 |
| 2026-02-17 | -35.01 |
| 2026-02-13 | -35.55 |
| 2026-02-12 | -34.29 |
| 2026-02-11 | -33.10 |
| 2026-02-10 | -34.32 |
| 2026-02-09 | -34.74 |
| 2026-02-06 | -33.77 |
| 2026-02-05 | -31.49 |
| 2026-02-04 | -34.32 |
| 2026-02-03 | -35.51 |
| 2026-02-02 | -35.55 |
| 2026-01-30 | -35.17 |
| 2026-01-29 | -37.30 |
| 2026-01-28 | -36.95 |
| 2026-01-27 | -39.09 |
| 2026-01-26 | -39.41 |
| 2026-01-23 | -40.19 |